No Data
No Data
Terumo has opened a new R&D facility in California, USA.
On March 31, 2025, Terumo Corporation (headquartered in Shibuya, Tokyo, President: Mitsuaki Samejima) will establish the corporate R&D satellite location in the USA, "D-TECT (Discovery and Technology Center of Terumo)," on April 1, 2025. The new location will have an office in Aliso Viejo, California, and aims to deepen collaborations with local medical institutions and keep abreast of trends in academia and startups.
The Nikkei average is down about 425 yen, with Advantest, SoftBank Group, and Tokyo Electron being the top contributors to the negative impact.
As of 12:47 PM on the 27th, the Nikkei Average stock price is around 37,600 yen, approximately 425 yen lower than the previous day. In the afternoon session, there is still a slight selling dominance, starting the trading with a widening decline compared to the morning closing price. Afterward, it fluctuates while showing stability. The foreign exchange market is stable at around 150.10 yen per dollar. The contribution degrees of the stocks adopted in the Nikkei Average show that Advantest <6857.T>, SoftBank Group <9984.T>, and Tokyo Electron <8035.T> are at the top with negative contributions. In positive contributions, Co...
Terumo To Go Ex-Dividend On March 28th, 2025 With 13 JPY Dividend Per Share
March 27th (Japan Standard Time) - $Terumo(4543.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 13 JPY dividend per share. The ex-dividend
At the end of the term, Institutions are mainly focused on rebalancing.
The Nikkei Average rebounded for the first time in four trading days, closing at 37,780.54 yen, up 172.05 yen (with an estimated Volume of 1.6 billion shares). Following the rise in the USA market, buying was led by semiconductor stocks and export-related stocks, which temporarily widened gains to 38,115.65 yen. However, at the recent resistance level, conflicting sentiments emerged, and after the initial wave of buying, the market gradually became more stagnated. Advantest <6857>, which started with buying, turned to decline early on, and as the afternoon session began, it widened its losses.
Terumo launches a new model of ECMO device.
On March 25, 2025, Terumo Corporation (headquartered in Shibuya, Tokyo, President: Mitsu Sakashima) announced the launch of the new model "Capiox Centrifugal Pump Controller SP-300", which drives the centrifugal pump for the extracorporeal circulation device that plays a core role in ECMO systems*1, used for emergency cardiopulmonary resuscitation during cardiac arrest and treatment of severe respiratory failure, to medical institutions nationwide.
The uncertainty surrounding Trump's tariffs is leading to a sense of stagnation.
The Nikkei average fell slightly for three consecutive trading days, ending at 37,608.49 yen, down 68.57 yen (Volume approximately 1.6 billion 50 million shares). Initially, buying began due to the rise in U.S. stocks at the end of last week, but after peaking at 37,841.68 yen at the open, the market showed a strong sense of stagnation. Uncertainty surrounding the Trump administration's tariff policies became a burden, leading to a slight movement as it ended at today's low. In the Main Board of the Tokyo Stock Exchange, the number of falling stocks exceeded 1,100, accounting for more than 60% of the total.
